HRP20020549B1 - Dna koja kodira novi rg1 polipeptid - Google Patents

Dna koja kodira novi rg1 polipeptid

Info

Publication number
HRP20020549B1
HRP20020549B1 HRP20020549AA HRP20020549A HRP20020549B1 HR P20020549 B1 HRP20020549 B1 HR P20020549B1 HR P20020549A A HRP20020549A A HR P20020549AA HR P20020549 A HRP20020549 A HR P20020549A HR P20020549 B1 HRP20020549 B1 HR P20020549B1
Authority
HR
Croatia
Prior art keywords
polypeptides
polypeptide
new
dna coding
methods
Prior art date
Application number
HRP20020549AA
Other languages
English (en)
Croatian (hr)
Inventor
Richard Harkins
Deborah Parkes
Gordon Parry
Douglas W. Schneider
Renate Steinbrecher
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of HRP20020549A2 publication Critical patent/HRP20020549A2/xx
Publication of HRP20020549B1 publication Critical patent/HRP20020549B1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
HRP20020549AA 1999-12-16 2000-12-15 Dna koja kodira novi rg1 polipeptid HRP20020549B1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
PCT/US2000/033901 WO2001044291A2 (en) 1999-12-16 2000-12-15 Polynucleotid encoding the rg1 polypeptide

Publications (2)

Publication Number Publication Date
HRP20020549A2 HRP20020549A2 (en) 2004-04-30
HRP20020549B1 true HRP20020549B1 (hr) 2013-09-30

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20020549AA HRP20020549B1 (hr) 1999-12-16 2000-12-15 Dna koja kodira novi rg1 polipeptid

Country Status (32)

Country Link
US (5) US6682902B2 (enExample)
EP (2) EP1237915B1 (enExample)
JP (1) JP4979867B2 (enExample)
KR (1) KR100752434B1 (enExample)
CN (1) CN1297566C (enExample)
AT (1) ATE440862T1 (enExample)
AU (1) AU784674B2 (enExample)
BG (1) BG65898B1 (enExample)
BR (1) BR0017022A (enExample)
CA (1) CA2394574A1 (enExample)
CZ (1) CZ299232B6 (enExample)
DE (1) DE60042836D1 (enExample)
DK (1) DK1237915T3 (enExample)
EE (1) EE05293B1 (enExample)
ES (1) ES2331106T3 (enExample)
HR (1) HRP20020549B1 (enExample)
HU (1) HU229001B1 (enExample)
IL (2) IL150115A0 (enExample)
LT (1) LT5046B (enExample)
ME (1) MEP37808A (enExample)
MX (1) MXPA02005914A (enExample)
NO (1) NO330924B1 (enExample)
NZ (1) NZ519598A (enExample)
PL (1) PL207634B1 (enExample)
PT (1) PT1237915E (enExample)
RO (1) RO122543B1 (enExample)
RS (1) RS50831B (enExample)
RU (1) RU2283130C2 (enExample)
SI (2) SI1237915T1 (enExample)
SK (2) SK288147B6 (enExample)
WO (1) WO2001044291A2 (enExample)
ZA (1) ZA200205638B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1251139A3 (en) * 1998-04-08 2002-12-18 Genentech, Inc. Human mindin-like protein and nucleic acids encoding it
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
MXPA06000798A (es) 2003-07-22 2006-04-07 Schering Ag Anticuerpos de rg1 y usos de los mismos.
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI494319B (zh) * 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
US20110020329A1 (en) * 2007-11-30 2011-01-27 Bristol-Myers Squibb Company Conjugates of anti-rg-1 antibodies
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045442A2 (en) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs
WO1998050073A1 (en) * 1997-05-09 1998-11-12 Smithkline Beecham Corporation Integrin ligand, human mindin
US5871969A (en) * 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
WO1993023057A1 (en) 1992-05-14 1993-11-25 Ribozyme Pharmaceuticals, Inc. Method and reagent for inhibiting cancer development
US6287777B1 (en) * 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6177244B1 (en) 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
CA2263895C (en) * 1996-08-26 2012-06-26 University Of Washington Therapeutic and diagnostic applications of perlecan domain i splice variants
EP0981625A2 (en) * 1997-05-06 2000-03-01 Human Genome Sciences, Inc. $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
JP2002527757A (ja) * 1998-10-19 2002-08-27 ダイアデクスアス・インコーポレーテッド 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EE05627B1 (et) * 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871969A (en) * 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
WO1998045442A2 (en) * 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs
WO1998050073A1 (en) * 1997-05-09 1998-11-12 Smithkline Beecham Corporation Integrin ligand, human mindin
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
MXPA02005914A (es) 2003-02-27
JP2003521244A (ja) 2003-07-15
EP2048157B1 (en) 2012-10-10
SI1237915T1 (sl) 2009-12-31
SK8482002A3 (en) 2003-02-04
CN1297566C (zh) 2007-01-31
EP1237915A2 (en) 2002-09-11
ATE440862T1 (de) 2009-09-15
US20020004047A1 (en) 2002-01-10
DK1237915T3 (da) 2009-11-16
SK288147B6 (sk) 2013-12-02
RU2002119208A (ru) 2004-02-27
CN1434832A (zh) 2003-08-06
IL150115A0 (en) 2002-12-01
WO2001044291A3 (en) 2002-01-17
YU44602A (sh) 2005-06-10
US6682902B2 (en) 2004-01-27
AU3074601A (en) 2001-06-25
CZ299232B6 (cs) 2008-05-21
SI21140A (sl) 2003-08-31
AU784674B2 (en) 2006-05-25
PL356220A1 (en) 2004-06-28
US20090292112A1 (en) 2009-11-26
DE60042836D1 (de) 2009-10-08
NO20022836L (no) 2002-08-15
EE05293B1 (et) 2010-04-15
ES2331106T3 (es) 2009-12-22
BG65898B1 (bg) 2010-04-30
EP2048157A1 (en) 2009-04-15
PL207634B1 (pl) 2011-01-31
HRP20020549A2 (en) 2004-04-30
MEP37808A (en) 2011-05-10
US20040023307A1 (en) 2004-02-05
JP4979867B2 (ja) 2012-07-18
IL150115A (en) 2013-11-28
EE200200323A (et) 2003-10-15
US20040152139A1 (en) 2004-08-05
HU229001B1 (en) 2013-07-29
HUP0204224A3 (en) 2004-12-28
US7307154B2 (en) 2007-12-11
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
ZA200205638B (en) 2003-10-15
RO122543B1 (ro) 2009-08-28
RU2283130C2 (ru) 2006-09-10
WO2001044291A2 (en) 2001-06-21
LT2002070A (en) 2003-04-25
LT5046B (lt) 2003-08-25
CA2394574A1 (en) 2001-06-21
HUP0204224A2 (hu) 2003-03-28
BG106823A (bg) 2003-04-30
US7893217B2 (en) 2011-02-22
KR20020065575A (ko) 2002-08-13
NO20022836D0 (no) 2002-06-14
NO330924B1 (no) 2011-08-22
US7887804B2 (en) 2011-02-15
BR0017022A (pt) 2002-11-05
KR100752434B1 (ko) 2007-08-27
SK286384B6 (sk) 2008-08-05
NZ519598A (en) 2004-03-26
US20090214422A1 (en) 2009-08-27
EP1237915B1 (en) 2009-08-26

Similar Documents

Publication Publication Date Title
HRP20020549B1 (hr) Dna koja kodira novi rg1 polipeptid
PL369741A1 (en) Immunocytokines with modulated selectivity
BR0206346A (pt) Proteìnas inseticidas de bacillus thuringiensis
WO2004069876A3 (en) Trimeric polypeptide construct to induce an enduring t cell response
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
NO995002D0 (no) Modifiserte TNF-<alfa>-molekyler, DNA som koder for slike modifiserte TNF-<alfa>-molekyler og vaksiner omfattende slike TNF-<alfa>-molekyler og DNA
FI954536A0 (fi) Eristettyjä nukleiinihappomolekyylejä, jotka koodittavat kasvainhyljintäantigeenin esiastetta MAGE-3, ja niiden hyötykäyttö
ZA909167B (en) Protein complexes having Factor VIII:C activity and production thereof
DE69830251D1 (de) Langes pentraxin ptx3 enthaltende pharmazeutische zusammensetzungen
DE60126737D1 (de) Modifizierte HPV E6- und E7-Gene und -Proteine als Impfstoff
NO20011460L (no) Cytokinreseptor zalphall
DE60118359D1 (de) Humanische pellino-polypeptide
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
ES2150937T3 (es) Autotaxina: proteina estimulante de la motilidad util en el diagnostico y terapia del cancer.
BR112022022615A2 (pt) Proteína nova e usos terapêuticos e cosméticos da mesma
ES2127192T3 (es) Polipeptidos especificos del epididimo y su aplicacion.
HK1048495A1 (zh) 脱氧核糖核酸编码的prost07多肽
DE60227367D1 (de) Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
WO2001042472A3 (en) DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE
ATE317896T1 (de) Polypeptide mit glucanotransferase aktivität und dafür kodierende nukleinsäuren
WO2003091402A3 (en) N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
DK1309690T3 (da) MFQ-111, et humant GTPase-lignende protein

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20131204

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20141215